Abstract OBJECTIVE: To study changes to CD4+CD25high+CD127low regulatory T cells (Treg) in peripheral blood from children with bronchiolitis, and to explore its clinical significance. METHODS: Thirty-one children with bronchiolitis and aged under two years were randomly enrolled as the bronchiolitis group, and 25 under two-year-olds with bronchopneumonia were randomly enrolled as the bronchopneumonia group. A further twenty-five children with non-infectious diseases such as hernia and renal calculus served as the control group. The level of CD4+CD25high+CD127lowTreg in peripheral blood was measured by multi-color detection and multi-parameter flow cytometry. RESULTS: The proportion of CD4+CD25high+CD127lowTreg in peripheral blood in the bronchiolitis group (8.0%±2.1%) was significantly lower than in the bronchopneumonia (9.6%±2.6%; P<0.05) and control groups (11.3%±2.9%; P<0.05). CONCLUSIONS: CD4+CD25high+CD127lowTreg level in peripheral blood may be an index of immunological function in infants. A decreased level of CD4+CD25high+CD127lowTreg in peripheral blood suggests that Treg cells may be involved in the pathogenesis and development of bronchiolitis.
WANG Xiu-Fang,GUO Zhi-Lan,LEI Rui-Rui et al. Changes to CD4+CD25high+CD127low regulatory T cells in peripheral blood from children with bronchiolitis, and its clinical significance[J]. CJCP, 2013, 15(1): 46-49.
WANG Xiu-Fang,GUO Zhi-Lan,LEI Rui-Rui et al. Changes to CD4+CD25high+CD127low regulatory T cells in peripheral blood from children with bronchiolitis, and its clinical significance[J]. CJCP, 2013, 15(1): 46-49.
［1］Kajosaari M, Syvanen P, Forars M, Juntunen-Backman K. Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma［J］. Pediatr Allergy Immu, 2000, 11(3): 198-202.
［2］Smit JJ, Boon L, Lukacs NW. Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8+T cells and interferon-gamma production［J］. Am J Pathol, 2007, 171(6): 1944-1951.
［6］Henness S, van Thoor E, Ge Q, Armour CL, Hughes JM, Ammit AJ. IL-17A act via p38 MAPK to increase stability of TNF-alpha-induce IL-8 mRNA in human ASM［J］. Am J Physiol Lung Cell Mol Physiol, 2006, 290(6): L1283-L1290.
［9］Wu HY, Maron R, Tukpah AM, Weiner HL. Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant［J］. J Immunol, 2010, 185(6): 3401-3407.
［10］Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cell［J］. J Exp Med, 2006, 203(7): 1693-1700.
［11］Openshaw PJ, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection［J］. Clin Microbiol Rev, 2005, 18(3): 541-555.
［12］Tripp RA, Oshansky C, Alvarez R. Cytokines and respiratory syncytial virus infection［J］. Proc Am Thorac Soc, 2005, 2(2): 147-149.
［13］Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis［J］. Am J Respir Crit Care Med, 2003, 168(6): 633-639.
［16］Zhu YF, Cai XH, Zhu JY, Jiang WP, Lan JH, Liu S. Study of CD4+CD25+ regulatory T cells and expression of Foxp3 mRNA in bronchiolitis and glucocorticoid regulation［J］. Zhonghua Yi Xue Za Zhi, 2009, 89(22): 1563-1566.
［17］Mailaparambil B, Grychtol R, Heinzmann A. Respiratory syncytial virus bronchiolitis and asthmainsights from recent studies and implications for therapy［J］. Inflamm Allergy Drug Targets, 2009, 8(3): 202-207.
